MedTrace Logo

Vitamin D Status and Dose Response in Infants

NCT01042561 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 64

Last updated 2023-09-01

No results posted yet for this study

Summary

This study will examine the relationship of serum 25(OH)D levels in infants 32 weeks and greater gestation who are fed infant formula to markers of inflammation and bone metabolism.

Conditions

  • Vitamin D
  • Prematurity

Interventions

DIETARY_SUPPLEMENT

Vitamin D3

400 IU of vitamin D3 daily. Pts will recieve 1 mL a day with a feeding for 28 days.

DIETARY_SUPPLEMENT

vitamin D3 placebo

Placebo designed by research pharmacist. Pts will recieve 1 mL a day with feedings for 28 days.

Sponsors & Collaborators

  • Creighton University Medical Center

    collaborator OTHER

  • University of Nebraska

    lead OTHER

Principal Investigators

  • Corrine Hanson, PhD, RD · University of Nebraska

Study Design

Allocation
RANDOMIZED
Purpose
DIAGNOSTIC
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
5 Minutes
Max Age
3 Months
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2009-08-07
Primary Completion
2010-08-01
Completion
2010-08-01

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01042561 on ClinicalTrials.gov